Zymergen

Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK, Aug. 15, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering (the "IPO" or "Offering"), of the important October 4, 2021 lead plaintiff deadline. SO WHAT: If you purchased Zymergen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zymergen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ZY

New York, New York--(Newsfile Corp. - August 13, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering (the "IPO" or "Offering"). A class action lawsuit has already...

ZY Shareholder Alert: Rosen, National Trial Counsel, Encourages Zymergen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ZY

Radnor, Pennsylvania--(Newsfile Corp. - August 13, 2021) -  The law firm of Kessler Topaz Meltzer & Check, LLP reminds Zymergen Inc. (NASDAQ: ZY) ("Zymergen") shareholders that a securities fraud class action lawsuit has been filed on behalf of those who purchased or acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering ("IPO").Lead Plaintiff Deadline: October...

Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Zymergen Inc.

Boston, Massachusetts--(Newsfile Corp. - August 13, 2021) - The Thornton Law Firm alerts investors who purchased Zymergen Inc. common stock (NASDAQ: ZY) pursuant or traceable to the registration statement and prospectus issued in connection with the Company's April 2021 initial public offering may seek to participate in the case as a Lead Plaintiff. Interested investors may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Zymergen for more information. Investors may also email investors@tenlaw.com...

ZYMERGEN INVESTOR ALERT: Shareholder Class Action Lawsuit Filed

SAN DIEGO--(BUSINESS WIRE)---- $ZY #LawFirm--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all persons and entities that purchased or acquired Zymergen Inc. (NASDAQ: ZY) stock in connection with the Company's April 2021 initial public offering ("IPO"). The complaint alleges violations of the Securities Exchange Act of 1933. Zymergen creates products that purportedly combine the design and manufacturing efficiency of biological processes with technology's abili

SHAREHOLDER ALERT: Robbins LLP Announces that Zymergen Inc. (ZY) is Being Sued for Misleading Shareholders

NEW YORK, Aug. 12, 2021 /PRNewswire/ --  Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased or otherwise acquired Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) securities pursuant and/or traceable to the offering documents issued in connection with Zymergen's April 2021 initial public offering (the "IPO"). All investors who purchased Zymergen Inc. and incurred losses are u rged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

ZYMERGEN INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Zymergen Inc.

San Diego, California--(Newsfile Corp. - August 12, 2021) - Robbins Geller Rudman & Dowd LLP announces that the Zymergen class action lawsuit charges Zymergen Inc. (NASDAQ: ZY), certain of its officers and directors, and the underwriters of Zymergen's April 2021 initial public offering ("IPO") with violations of the Securities Act of 1933 and seeks to represent purchasers of Zymergen common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued...

NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Zymergen Inc. Class Action Lawsuit - ZY

Concho Resources

Didi Global

NEW YORK, NY / ACCESSWIRE / August 12, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DIDI, CXO and ZY

RYE BROOK, N.Y.--(BUSINESS WIRE)--Klafter Lesser LLP, which has extensive experience in recovering investor losses, announces that a class action lawsuit has been filed (21-cv-06028, N.D. Cal.) against Zymergen, Inc. (NASDAQ:ZY) on behalf of persons or entities that purchased or otherwise acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with Zymergen's April 2021 IPO. After the close of the markets on August 3, 2021, Zyme

Zymergen Investor Alert - Klafter Lesser LLP, a Highly Accomplished Class Action Law Firm, Announces That a Class Action Has Been Filed

San Francisco, California--(Newsfile Corp. - August 11, 2021) -   Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses now. Class Period: Apr. 20, 2021 - Aug. 4, 2021Lead Plaintiff Deadline: Oct. 4, 2021Visit: www.hbsslaw.com/investor-fraud/ZY Contact An Attorney Now: ZY@hbsslaw.com 844-916-0895Zymergen Inc. (ZY) Securities Class Action: The case arises from Zymergen's misrepresentations in its Registration Statement for its...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Zymergen (ZY) Investors to Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys Now

Boston, Massachusetts--(Newsfile Corp. - August 11, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Zymergen Inc. (NASDAQ: ZY). The case is currently in the lead plaintiff stage. Investors who purchased ZY common stock pursuant or traceable to the registration statement and prospectus issued in connection with the Company's April 2021 initial public offering may contact the Thornton Law Firm's investor protection team...

Zymergen Investor Alert: Class Action Lawsuit Filed

NEW YORK, Aug. 10, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering (the "IPO" or "Offering"). A class action lawsuit has already been filed.

ROSEN, A TOP RANKED LAW FIRM, Encourages Zymergen Inc. Investors with Losses to Secure Counsel Before Important Deadline - ZY

NEW YORK, Aug. 10, 2021 /PRNewswire/ -- Attorney Advertising- - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zymergen, Inc.  ("Zymergen" or the "Company") (NASDAQ: ZY) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's April 2021 initial public offering ("IPO" or the "Offering"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/zy.

ZY Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Zymergen, Inc. Investors of Class Action and Encourages Investors to Contact the Firm

BlueCity Holdings Limited

Coinbase

NEW YORK, NY / ACCESSWIRE / August 10, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.

CLASS ACTION UPDATE for BLCT, COIN and ZY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)-- #ZYstock--The suit alleges defendants issued false statements concerning Zymergen business and prospects, resulting in its stock trading at inflated prices.

ZY DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Zymergen Inc. Class Action Lawsuit

New York, New York--(Newsfile Corp. - August 9, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) from April 20, 2021 through August 4, 2021 (the "Class Period"). The lawsuit filed in the...

ZY FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Zymergen, Inc.

RLX Technology

Stable Road Acquisition Corp

NEW YORK, NY / ACCESSWIRE / August 9, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, RLX and ZY

Amyris

The flashy synthetic-biology start-up ran into a wall that Amyris has already learned how to climb over.

Zymergen's Implosion Makes Amyris a Screaming Buy

Churchill Capital Corp IV

NEW YORK, NY / ACCESSWIRE / August 9, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.

CLASS ACTION UPDATE for CCIV, DIDI and ZY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Cathie Wood-led Ark Invest said on Friday it continues to believe Zymergen Inc (NASDAQ:ZY)'s platform holds deep intrinsic value despite the recent setback and a lowered short-term outlook.  What Happened: Zymergen shares rallied 75% a day after Wood's firm snapped up shares in the biofacturing company, reversing the losses of the previous day.

Zymergen Holds 'Deep Intrinsic Value' Despite Wobbly Short-Term Outlook, Says Cathie Wood's Ark

RADNOR, Pa.--(BUSINESS WIRE)---- $ZY #classaction--Kessler Topaz Meltzer & Check, LLP Reminds Zymergen Inc. Shareholders of Securities Fraud Class Action Lawsuit

ZY CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Zymergen Inc. Shareholders of Securities Fraud Class Action Lawsuit

CorMedix

NEW YORK, NY / ACCESSWIRE / August 8, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

SHAREHOLDER ALERT: DIDI CRMD ZY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

RADNOR, Pa., Aug. 7, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Zymergen Inc. (NASDAQ: ZY) ("Zymergen") on behalf of those who purchased or acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering ("IPO").

Zymergen Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Zymergen Inc.

NEW YORK, Aug. 6, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) from April 20, 2021 through August 4, 2021 (the "Class Period"). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Act of 1933.

ZY INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Zymergen, Inc.

The momentum that the stock gained during Thursday's trading session couldn't be sustained.

News for Zymergen Stock (ZY)